Usefulness of CA 19-9 for pancreatic cancer screening in patients with new-onset diabetes.

Hepatobiliary & Pancreatic Diseases International(2018)

引用 20|浏览24
暂无评分
摘要
CA 19-9 levels after a diagnosis of new-onset DM could be a useful biomarker of pancreatic cancer, especially in patients with high serum bilirubin.
更多
查看译文
关键词
Diabetes mellitus,Pancreatic neoplasms,Early detection of cancer,Carbohydrate antigen 19–9,Bilirubin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要